IHE : iShares U.S. Pharmaceuticals ETF

IHE is a Sector Equity Market Healthcare with LOW fees.

IHE

iShares U.S. Pharmaceuticals ETF

FI Score

60 /100

Diversification Rating

10 /10

Expense Ratio Rating

8 /10

Expense Rating

6 /10

Market Score

4 /10

Category Score

0 /10

Market Size

4 /10

60% FI Score
  • ihe
  • ETF
  • Sector Equity
  • Healthcare

iShares U.S. Pharmaceuticals ETF

Expenses: 0.42% (Better than 1% of similar funds)

This is an OK choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

Largest Holdings

Amount Holding
20.50% Johnson & Johnson
17.38% Merck & Co., Inc
5.62% Catalent, Inc
4.87% Zoetis Inc
4.56% Horizon Therapeutics Public Limited Company
4.53% Elanco Animal Health Incorporated
4.45% Mylan, Inc
4.43% Bristol-Myers Squibb Company
4.04% Pfizer Inc
3.96% Eli Lilly and Company

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo